United States · FDA National Drug Code directory
Icatibant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-3066_56c3b3d7-5c66-422c-a72d-30b3599d71db
- Product NDC
- 0093-3066
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Icatibant
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190715
- Source listing expiry
- 20261231
Source-listed ingredients
- ICATIBANT ACETATE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (0093-3066-34) / 3 mL in 1 SYRINGE · 0093-3066-34
- 3 CARTON in 1 BOX (0093-3066-93) / 1 SYRINGE in 1 CARTON (0093-3066-19) / 3 mL in 1 SYRINGE · 0093-3066-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →